General Information of the Compound
Compound ID
CP0544163
Compound Name
4-(5-chloropyridin-2-yl)-N-(1H-indazol-6-yl)piperazine-1-carboxamide
    Show/Hide
Structure
Formula
C17H17ClN6O
Molecular Weight
356.817
Canonical SMILES
Clc1ccc(nc1)N1CCN(CC1)C(=O)Nc1ccc2cn[nH]c2c1
    Show/Hide
InChI
InChI=1S/C17H17ClN6O/c18-13-2-4-16(19-11-13)23-5-7-24(8-6-23)17(25)21-14-3-1-12-10-20-22-15(12)9-14/h1-4,9-11H,5-8H2,(H,20,22)(H,21,25)
    Show/Hide
InChIKey
YDHVRKLICPIOOQ-UHFFFAOYSA-N
Physicochemical Property
logP
2.9654
Rotatable Bonds
2
Heavy Atom Count
25
Polar Areas
77.15
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168277599
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 1.62 nM
   TI
   LI
   LO
   TS